High-Throughput Screening of Small Molecule Transcriptional Regulators in Embryonic Stem Cells Using qRT-PCR

  • Emily C. DykhuizenEmail author
  • Leigh C. Carmody
  • Nicola J. Tolliday
Part of the Methods in Pharmacology and Toxicology book series (MIPT)


While quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) is a standard tool for many laboratories studying gene regulation, it is not commonly used for small molecule screening. More commonly, high throughput screens (HTSs) designed to detect transcriptional changes use a gene reporter, such as green fluorescent protein (GFP), β-galactosidase, or luciferase. The downsides of this approach include the genetic manipulation required to make reporter lines, the artifacts introduced by this indirect measurement, and the limited number of genes that can be monitored. Here we describe a method for using qRT-PCR to assay the regulation of multiple genes in a 384-well format. We envision this technology being utilized in three main scenarios: screening against cell lines that are not amenable to genetic manipulation (such as lines derived from patients), screening for transcriptional regulators without well-defined functions, or as a secondary screen validating results obtained using a traditional reporter cell line or biochemical readout. Additionally, we provide useful guidelines and protocols for culturing and plating mouse embryonic stem (ES) cells for high throughput screening. While embryonic stem cells are of great interest for regenerative medicine and are a useful tool for studying the epigenetic regulation of cell identity, they are difficult to culture and require extra care and consideration. We provide a method for culturing and plating mouse ES cells in 384-well format.

Key words

High-throughput screening Embryonic stem cells Epigenetics qRT-PCR Transcriptional assay Real-time PCR 


  1. 1.
    Eggert US (2013) The why and how of phenotypic small-molecule screens. Nat Chem Biol 9:206–209CrossRefPubMedGoogle Scholar
  2. 2.
    Zhang Z, Guan N, Li T, Mais DE, Wang M (2012) Quality control of cell-based high-throughput drug screening. Acta Pharm Sin B 2:429–438CrossRefGoogle Scholar
  3. 3.
    Auld DS, Thorne N, Nguyen D-T, Inglese J (2008) A specific mechanism for nonspecific activation in reporter-gene assays. ACS Chem Biol 3:463–470CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Rao SSP et al (2014) A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell 159:1665–1680CrossRefPubMedGoogle Scholar
  5. 5.
    Kagey MH et al (2010) Mediator and cohesin connect gene expression and chromatin architecture. Nature 467:430–435CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Ho L et al (2009) An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc Natl Acad Sci 106:5187–5191CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Dykhuizen EC, Carmody LC, Tolliday N, Crabtree GR, Palmer MAJ (2012) Screening for inhibitors of an essential chromatin remodeler in mouse embryonic stem cells by monitoring transcriptional regulation. J Biomol Screen 17:1221–1230CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Ho L et al (2009) An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency. Proc Natl Acad Sci 106:5181–5186CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Wu J, Lessard J, Crabtree G (2009) Understanding the words of chromatin regulation. Cell 136:200–206CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kadoch C et al (2013) Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat Genet 45:592–601CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Bultman S, Gebuhr T, Magnuson T (2005) A Brg1 mutation that uncouples ATPase activity from chromatin remodeling reveals an essential role for SWI/SNF-related complexes in beta-globin expression and erythroid development. Gene Dev 19:2849–2861CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Phelan M, Sif S, Narlikar G (1999) Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol Cell 3(2):247–253CrossRefPubMedGoogle Scholar
  13. 13.
    Ho L et al (2011) esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function. Nat Cell Biol 13:903–913CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Lessard J, Sauvageau G (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423:255–260CrossRefPubMedGoogle Scholar
  15. 15.
    Kreso A et al (2014) Self-renewal as a therapeutic target in human colorectal cancer. Nat Med 20:29–36CrossRefPubMedGoogle Scholar
  16. 16.
    Bittker JA (2012) High-Throughput RT-PCR for small-molecule screening assays. Curr Protoc Chem Biol 4:49–63PubMedPubMedCentralGoogle Scholar
  17. 17.
    Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods 25(4):402–408CrossRefPubMedGoogle Scholar
  18. 18.
    Lundholt BK, Scudder KM, Pagliaro L (2003) A simple technique for reducing edge effect in cell-based assays. J Biomol Screen 8(5):566–570CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2017

Authors and Affiliations

  • Emily C. Dykhuizen
    • 1
    Email author
  • Leigh C. Carmody
    • 2
  • Nicola J. Tolliday
    • 2
  1. 1.Department of Medicinal Chemistry and Molecular PharmacologyPurdue UniversityWest LafayetteUSA
  2. 2.Center for the Development of TherapeuticsBroad Institute of Harvard and MITCambridgeUSA

Personalised recommendations